600549:SSEXiamen Tungsten Co. Ltd. Class A Analysis
Data as of 2026-06-14 - not real-time
CN¥64.80
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Xiamen Tungsten is trading close to a key resistance level while technical momentum remains bullish, as the MACD line sits comfortably above its signal and the RSI stays in the upper‑mid range. Increasing volume supports the recent price strength, yet the price remains well above the computed support zone, indicating limited downside cushion.
Fundamentally, the stock appears markedly overvalued, with a price‑to‑earnings multiple that far exceeds its discounted cash‑flow estimate and a modest dividend yield that may be hard to sustain given negative free cash flow. The company’s debt profile is moderate and return on equity is respectable, but the reliance on commodity markets adds sector‑specific volatility. Investors should weigh the bullish technical backdrop against the substantial valuation gap and cash‑flow concerns before deciding on exposure.
Fundamentally, the stock appears markedly overvalued, with a price‑to‑earnings multiple that far exceeds its discounted cash‑flow estimate and a modest dividend yield that may be hard to sustain given negative free cash flow. The company’s debt profile is moderate and return on equity is respectable, but the reliance on commodity markets adds sector‑specific volatility. Investors should weigh the bullish technical backdrop against the substantial valuation gap and cash‑flow concerns before deciding on exposure.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price near resistance with limited upside
- overvaluation relative to intrinsic estimate
- high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- bullish technical momentum persisting
- steady dividend payout despite cash‑flow pressure
- moderate debt and solid return on equity
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- valuation gap unlikely to close without fundamental improvement
- exposure to commodity price cycles
- negative free cash flow raising sustainability doubts
Key Metrics & Analysis
Financial Health
Revenue Growth87.00%
Profit Margin5.66%
P/E Ratio33.9
ROE16.85%
ROA6.51%
Debt/Equity54.07
P/B Ratio5.6
Op. Cash FlowCN¥795.1M
Free Cash FlowCN¥-2288632064
Technical Analysis
TrendNeutral
RSI60.3
SupportCN¥49.30
ResistanceCN¥70.13
MA 20CN¥56.76
MA 50CN¥57.82
MA 200CN¥46.40
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueCN¥7.09
GradeOvervalued
TypeGrowth
Dividend Yield1.55%
Risk Assessment
Beta0.19
Volatility64.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.